COVID-19 e os olhos: O que Esperar/COVID-19 and the eyes: What to Expect
DOI:
https://doi.org/10.34119/bjhrv3n5-302Keywords:
Covid-19, Coronavirus, Conjuntivite, Saúde ocular.Abstract
O SARS-CoV-2 é um vírus altamente transmissível, que se propaga através do contato entre os indivíduos, através de gotículas respiratórias ou quando há contato com superfícies contaminadas previamente. Até o momento, as evidências disponíveis sobre outras vias de transmissão do vírus são limitadas, entretanto, é importante ressaltar que os olhos podem ser uma via alternativa de contágio através de suas secreções. Este artigo visa demonstrar as manifestações oculares descritas até o momento em pacientes com diagnóstico da COVID-19.
References
He F, Deng Y, Li W. Coronavirus disease 2019: What We Know?. J Med Virol. 2020; 1-7.
Junior SA, Kairala RCO, Pereira AG, Costa GB, Cruz RCR, et al. COVID-19 e a infecção por SARS-CoV-2 em um panorama geral. Brazilian Journal of Health Review, Vol 3, No 2, 2020.
Napoli PE, Nioi M, D’Aloja E, Fossarello M. The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist?. J. Clin. Med. 2020, 9(5), 1269.
Wu P, Duan F, Luo C, Lio C, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol, Published online March 2020.
Villahoz NG, Blasco BB, Vilela AA, Villalobos PA, Luna CMR, Sardina RC, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19?. J Med Virol. 2020 Jun 24; 10.1002.
Villahoz NG, Blasco BB, Villegas BV, Feijoo JG, Villalobos PA, Casa JMM, et al. Novel Insights into the Transmission of SARS-CoV-2 Trough the Ocular Surface and its Detection in Tears and Conjuntival Secretions: A Review. Advances in Therapy, volume 37, pages4086–4095(2020).
Willcox MD, Walsh K, Nichols JJ, Morgan PB, Jones LW. The ocular surface, coronaviruses and COVID-19. Clin Exp Optom, 2020 Jul; 103(4):418-424.
Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations. Ocul Immunol Inflamm. 2020 Jul 3;28(5):726-734.
Hoffmann M, Weber KH, Schroeder S, Muller MA, Drosten C, Pohlmann S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Volume 181, Issue 2, P271-289. E8, april 16, 2020.
Lauande R, Paula JS. Coronavirus and the eye: what is relevant so far?. Arq. Bras. Oftalmol. vol.83 no.3 São Paulo May/June 2020 Epub May 29, 2020.
Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort Jr R. Retinal Findings in patients with COVID-19. The Lancet, volume 395, issue 10237, P1610. May 23, 2020.
American Academy of Ophthalmology. Symptomatic COVID-19 in Eye Professionals in Wuhan, China. Report, Volume 127, issue 9, P1268-1270, SEPTEMBER 01, 2020.
Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, et al. COVID-19: Limiting the Risks for Eye Care Professionals. Ocular Immunology and Inflammation, 2020.
Li JPO, Lam DSC, Shen Y, Ting DSW. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol, March 2020; Vol 104 No 3.
